Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularization
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/10216/157462 |
Resumo: | Impaired angiogenesis in skin chronic wounds prolongs inflammation and compromises wound healing. Several strategies have been attempted to improve vascularization, such as application of growth factors, like the vascular endothelial growth factor (VEGF). However, VEGF is expensive, has a short half-life in vivo and has been associated to tumorigenesis when used in high concentrations. QK peptide is a shorter (15 amino acids), synthetic, VEGF-mimetic peptide with improved stability and lower production cost. However, the residence time and half-life of QK may be further improved by conjugation to nanoparticles (NP). Herein, QK was conjugated onto norbornene-chitosan (NorChit) NP in a “one-pot" microfluidics device using thiol-norbornene “photoclick” chemistry. An in vitro proliferation assay using human umbilical vein endothelial cells (HUVEC) showed the higher efficacy of QK-NorChit NP (Ø = 111 ± 74 nm) in inducing HUVEC metabolic activity compared to soluble Cys-QK, highlighting the advantage of conjugation. However, when tested in vivo (chick chorioallantoic membrane assay; CAM), all the NP were pro-angiogenic, regardless of being decorated with QK or not. Interestingly, bare NorChit NP were superior to both VEGF and QK-NorChit NP in stimulating angiogenesis. Therefore, NorChit NP with and without QK may be useful to promote vascularization in chronic wounds. |
id |
RCAP_aeb80e921aed87a295f23a3e2e95e3ea |
---|---|
oai_identifier_str |
oai:repositorio-aberto.up.pt:10216/157462 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularizationAngiogenesisQK peptideSkin chronic woundsThiol-eneVEGF mimeticImpaired angiogenesis in skin chronic wounds prolongs inflammation and compromises wound healing. Several strategies have been attempted to improve vascularization, such as application of growth factors, like the vascular endothelial growth factor (VEGF). However, VEGF is expensive, has a short half-life in vivo and has been associated to tumorigenesis when used in high concentrations. QK peptide is a shorter (15 amino acids), synthetic, VEGF-mimetic peptide with improved stability and lower production cost. However, the residence time and half-life of QK may be further improved by conjugation to nanoparticles (NP). Herein, QK was conjugated onto norbornene-chitosan (NorChit) NP in a “one-pot" microfluidics device using thiol-norbornene “photoclick” chemistry. An in vitro proliferation assay using human umbilical vein endothelial cells (HUVEC) showed the higher efficacy of QK-NorChit NP (Ø = 111 ± 74 nm) in inducing HUVEC metabolic activity compared to soluble Cys-QK, highlighting the advantage of conjugation. However, when tested in vivo (chick chorioallantoic membrane assay; CAM), all the NP were pro-angiogenic, regardless of being decorated with QK or not. Interestingly, bare NorChit NP were superior to both VEGF and QK-NorChit NP in stimulating angiogenesis. Therefore, NorChit NP with and without QK may be useful to promote vascularization in chronic wounds.Elsevier20242024-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/157462eng2468-519410.1016/j.mtchem.2024.101942Alves, PMFonseca, DRBidarra, SJGomes, AGomes, PBarrias, CCMartins, MCLinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-08T01:19:06Zoai:repositorio-aberto.up.pt:10216/157462Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:10:59.302663Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularization |
title |
Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularization |
spellingShingle |
Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularization Alves, PM Angiogenesis QK peptide Skin chronic wounds Thiol-ene VEGF mimetic |
title_short |
Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularization |
title_full |
Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularization |
title_fullStr |
Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularization |
title_full_unstemmed |
Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularization |
title_sort |
Norbornene-chitosan nanoparticles with and without a conjugated VEGF-peptide analog to promote vascularization |
author |
Alves, PM |
author_facet |
Alves, PM Fonseca, DR Bidarra, SJ Gomes, A Gomes, P Barrias, CC Martins, MCL |
author_role |
author |
author2 |
Fonseca, DR Bidarra, SJ Gomes, A Gomes, P Barrias, CC Martins, MCL |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Alves, PM Fonseca, DR Bidarra, SJ Gomes, A Gomes, P Barrias, CC Martins, MCL |
dc.subject.por.fl_str_mv |
Angiogenesis QK peptide Skin chronic wounds Thiol-ene VEGF mimetic |
topic |
Angiogenesis QK peptide Skin chronic wounds Thiol-ene VEGF mimetic |
description |
Impaired angiogenesis in skin chronic wounds prolongs inflammation and compromises wound healing. Several strategies have been attempted to improve vascularization, such as application of growth factors, like the vascular endothelial growth factor (VEGF). However, VEGF is expensive, has a short half-life in vivo and has been associated to tumorigenesis when used in high concentrations. QK peptide is a shorter (15 amino acids), synthetic, VEGF-mimetic peptide with improved stability and lower production cost. However, the residence time and half-life of QK may be further improved by conjugation to nanoparticles (NP). Herein, QK was conjugated onto norbornene-chitosan (NorChit) NP in a “one-pot" microfluidics device using thiol-norbornene “photoclick” chemistry. An in vitro proliferation assay using human umbilical vein endothelial cells (HUVEC) showed the higher efficacy of QK-NorChit NP (Ø = 111 ± 74 nm) in inducing HUVEC metabolic activity compared to soluble Cys-QK, highlighting the advantage of conjugation. However, when tested in vivo (chick chorioallantoic membrane assay; CAM), all the NP were pro-angiogenic, regardless of being decorated with QK or not. Interestingly, bare NorChit NP were superior to both VEGF and QK-NorChit NP in stimulating angiogenesis. Therefore, NorChit NP with and without QK may be useful to promote vascularization in chronic wounds. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024 2024-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/10216/157462 |
url |
https://hdl.handle.net/10216/157462 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2468-5194 10.1016/j.mtchem.2024.101942 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137759710937088 |